44.32
Schlusskurs vom Vortag:
$44.65
Offen:
$44.49
24-Stunden-Volumen:
1.28M
Relative Volume:
1.09
Marktkapitalisierung:
$9.68B
Einnahmen:
$2.04B
Nettoeinkommen (Verlust:
$373.39M
KGV:
26.13
EPS:
1.6961
Netto-Cashflow:
$495.96M
1W Leistung:
+1.74%
1M Leistung:
-6.69%
6M Leistung:
+7.70%
1J Leistung:
+2.37%
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
QGEN
Qiagen Nv
|
44.32 | 9.68B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Qiagen N.V. $QGEN Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Is Qiagen N.V. (QIA) stock a defensive play amid uncertaintyJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Can Qiagen N.V. (QIA) stock resist broad market declinesMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com
What momentum shifts mean for Qiagen N.V.2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Will breakout in Qiagen N.V. lead to full recoveryQuarterly Market Summary & Verified Chart Pattern Signals - newser.com
Using portfolio simulators with Qiagen N.V. includedGold Moves & Reliable Entry Point Alerts - newser.com
Is Qiagen N.V. Common Shares stock testing key support2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
Will Qiagen N.V. see short term momentumJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Is Qiagen N.V. (QIA) stock a top hedge fund pickJuly 2025 Patterns & Weekly High Momentum Picks - newser.com
Is Qiagen N.V. stock attractive for passive investorsCEO Change & Consistent Growth Equity Picks - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
164,900 Shares in Qiagen N.V. $QGEN Purchased by Jupiter Asset Management Ltd. - MarketBeat
What data driven models say about Qiagen N.V.’s futureExit Point & Weekly Momentum Picks - newser.com
How Qiagen N.V. Common Shares stock performs in easing cyclesJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Is Qiagen N.V. stock cheap at current valuationTake Profit & Precise Swing Trade Entry Alerts - newser.com
Is Qiagen N.V. stock a safe haven asset2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Wellington Management Group LLP Reduces Stake in Qiagen NV - GuruFocus
Is Qiagen N.V. Common Shares stock a buy for dividend portfoliosTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - newser.com
Will Qiagen N.V. (QIA) stock keep high P E multiplesEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com
Can Qiagen N.V. stock hit record highs againJuly 2025 Chart Watch & Smart Investment Allocation Tips - Fundação Cultural do Pará
Bank of New York Mellon Corp Has $39.79 Million Holdings in Qiagen N.V. $QGEN - MarketBeat
Is Qiagen N.V. stock cheap compared to fundamentalsJuly 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
Full technical analysis of Qiagen N.V. stockEarnings Miss & Weekly Breakout Stock Alerts - newser.com
What downside risks could hit Qiagen N.V. Common Shares stockJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Volume spikes in Qiagen N.V. stock – what they meanQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Pryor Cashman Represents Soleus Capital In Sale Of Parse Biosciences To QIAGEN N.V. For Up To $280 Million - MarketScreener
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):